Shots: Amgen has consummated the purchase of Astellas’49% shares of AABP, a JV between Amgen and Astellas established in 2013 AABP now serves as a wholly-owned Amgen affiliate in Japan […]readmore
Tags : Presence
Shots: Samsung Biologics entered into an agreement with APRINOIA Therapeutics to develop an anti-tau mAb for treating primary and secondary tauopathies, including PSP and AD APRINOIA will utilize its Ab […]readmore
Shots: Zuellig Pharma acquires Alliance Pharma for enhancing the access to healthcare for Cambodian people by combining their reach and capabilities in Cambodia The focus of the acquisition is to […]readmore
Shots: STADA to acquire Biopharma’s pharmaceutical prescription and consumer health business including local manufacturing operations and ~300 new staff. Biopharma will retain its blood plasma-based business and will focus on […]readmore
Shots: Astellas to receive ~$88.3M as up front for its three products. Daiichi to get rights and obligations, including manufacturing and marketing approvals for Nasea (ramosetron), Perdipine (nicardipine) and Oldeca […]readmore